| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Prime Medicine, Inc. | Member of 10% Group | Common Stock | 3,200,000 | $20,000,000 | $6.25 | 20 Feb 2024 | By GV 2023, L.P. |
| Verve Therapeutics, Inc. | Member of 10% Group | Common Stock | 1,800,000 | $18,000,000 | $10.00 | 01 Dec 2023 | By GV 2023, L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PRME | Prime Medicine, Inc. | 20 Feb 2024 | 0 | $0 | 3 | Member of 10% Group | 29 Feb 2024, 16:21 |
| VERV | Verve Therapeutics, Inc. | 01 Dec 2023 | 0 | $0 | 3 | Member of 10% Group | 05 Dec 2023, 16:50 |